Search results for "treatment strategy"

showing 10 items of 40 documents

The outcomes of Ilizarov treatment in aseptic nonunions of the tibia stratified by treatment strategies and surgical techniques.

2020

Abstract INTRODUCTIONNonunions of the tibia, particularly those located in the distal third of the bone, are relatively common in clinical practice. There is no gold standard for the treatment of nonunions of the tibia. The purpose of our study was to assess the results of treatment with the Ilizarov method in patients with aseptic nonunions of the tibia, depending on the employed treatment strategies and surgical techniques.MATERIALS AND METHODSA total of 75patients with Ilizarov treatment of aseptic nonunions of the tibia were evaluated in the study. The patients’s mean age at the beginning of treatment was 46years.The mean follow-up period was 10years and 11months.The evaluated patients …

Ilizarov Techniquemusculoskeletal diseasesAdultMalemedicine.medical_specialtyAdolescentScienceIlizarov TechniqueTraumaArticlelaw.inventionIntramedullary rod03 medical and health sciencesFixation (surgical)Young Adult0302 clinical medicinelawFracture fixationmedicineHumans030212 general & internal medicineTibiaAgedAged 80 and over030222 orthopedicsMultidisciplinaryTibiabusiness.industryQRMean ageHypertrophyMiddle Agedmusculoskeletal systemSurgeryFracture Fixation IntramedullaryTibial FracturesRisk factorsFractures UnunitedMedicineTreatment strategyFemaleAseptic processingbusinessScientific reports
researchProduct

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

2022

Treatment for hepatocellular carcinoma (HCC) has experienced major advancements since the last update of the official Barcelona Clinic Liver Cancer (BCLC) prognosis and treatment strategy published in 2018. Advancements in the field have emerged in all areas, but in this manuscript, we present those that have primed a change in the strategy and comment why some encouraging data in select interventions are still considered immature and in need of further research to gain their incorporation into an evidence-based model for clinicians and researchers. Finally, we describe the critical insight and expert knowledge that is needed to take clinical decisions in individual patients so that the rec…

MaleLiver CancerPrognosis predictionmedicine.medical_specialtyCarcinoma HepatocellularTare weightliver transplantation TACEAFPClinical Trials and Supportive ActivitiesClinical SciencesPsychological interventionSeverity of Illness IndexablationsurvivalArticleTAREsurgeryRare DiseasesClinical ResearchMedicineHepatectomyHumansHCCIntensive care medicineStaging systemNeoplasm StagingCancerHepatologyGastroenterology & Hepatologybusiness.industryLiver DiseaseCarcinomaLiver NeoplasmsALBI scoreHepatocellularsystemic treatmentMiddle Agedmedicine.diseasePrognosisBCLCGood Health and Well BeingHepatocellular carcinomaPublic Health and Health ServicesTreatment strategyFemalebusinessLiver cancerDigestive Diseases
researchProduct

Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?

2019

Gender differences play a pivotal role in the pathophysiology and treatment of major depressive disorder. This is strongly supported by a mean 2:1 female-male ratio of depression consistently observed throughout studies in developed nations. Considering the urgent need to tailor individualized treatment strategies to fight depression more efficiently, a more precise understanding of gender-specific aspects in the pathophysiology and treatment of depressive disorders is fundamental. However, current treatment guidelines almost entirely neglect gender as a potentially relevant factor. Similarly, the vast majority of animal experiments analysing antidepressant treatment in rodent models exclus…

MalePsychotherapistsex differencemedia_common.quotation_subjectmedicine.medical_treatmentReviewelectroconvulsive therapyCatalysisNeglectlcsh:ChemistryInorganic Chemistryendocrinology03 medical and health sciences0302 clinical medicineElectroconvulsive therapygendermedicineAnimalsHumansPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyDepression (differential diagnoses)media_commonDepressive Disorder Majorantidepressantbusiness.industryOrganic ChemistryGeneral MedicineRapid-acting antidepressantrapid-actingmedicine.diseaseAntidepressive Agents030227 psychiatryComputer Science ApplicationsReview articleTreatment Outcomelcsh:Biology (General)lcsh:QD1-999(2R6R)-HydroxynorketaminedepressionTreatment strategyAntidepressantMajor depressive disorderFemaleKetaminebusiness030217 neurology & neurosurgery
researchProduct

Long-Term Follow-Up of Repeat Endoscopic Third Ventriculostomy in Obstructive Hydrocephalus.

2017

Endoscopic third ventriculostomy (ETV) is a safe and less-invasive treatment strategy for patients with obstructive hydrocephalus and provides excellent outcome. Nevertheless, repeat ETV in cases of ETV failure is a controversial issue.Between 1993 and 1999, 113 patients underwent a total of 126 ETVs at the Department of Neurosurgery, Mainz University Hospital. Obstructive hydrocephalus was the causative pathology in all cases. A very long-term follow-up of up to 16 years could be achieved. All medical reports of patients who received ETV were reviewed and analyzed with focus on ETV failure with following repeat ETV and its initial as well as very long-term success.Thirty-one events of ETV …

MaleReoperationmedicine.medical_specialtyPediatricsAdolescentLong term follow upObstructive hydrocephalusConstriction PathologicVentriculostomyCentral Nervous System Neoplasms03 medical and health sciencesYoung Adult0302 clinical medicinemedicineHumansTreatment FailureChildRetrospective StudiesThird Ventriclebusiness.industryCystsEndoscopic third ventriculostomyCerebral AqueductInfantUniversity hospitalSurgeryTreatment Outcome030220 oncology & carcinogenesisChild PreschoolNeuroendoscopyCerebrospinal fluid circulationTreatment strategySurgeryFemaleNeurology (clinical)NeurosurgerybusinessIntracranial Hemorrhages030217 neurology & neurosurgeryFollow-Up StudiesHydrocephalusWorld neurosurgery
researchProduct

Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronar…

2019

Background: Nowadays, the majority of patients with myocardial infarction with ST-segment elevation (STEMI) are treated with primary percutaneous coronary interventions (PCI). In recent years, there have been ongoing improvements in PCI techniques, devices and concomitant pharmacotherapy. However, reports on further mortality reduction among PCI-treated STEMI patients remain inconclusive. The aim of this study was to compare changes in management and mortality in PCI-treated STEMI patients between 2005 and 2011 in a real-life setting. Methods: Data on 79,522 PCI-treated patients with STEMI from Polish Registry of Acute Coronary Syndromes (PL-ACS) admitted to Polish hospitals between 2005 an…

MaleTime Factorsmedicine.medical_treatment030204 cardiovascular system & hematology0302 clinical medicinetemporal trendsRisk Factorstreatment strategyST segmentMyocardial infarctionHospital MortalityRegistriesPractice Patterns Physicians'Mortality rateGeneral MedicineMiddle AgedInterventional Cardiologysurgical procedures operativeTreatment OutcomePractice Guidelines as TopicCardiologyFemaleStentsGuideline AdherenceCardiology and Cardiovascular Medicinemedicine.medical_specialtyRisk Assessment03 medical and health sciencesPharmacotherapyPercutaneous Coronary InterventionSex FactorsInternal medicinemedicineHumanscardiovascular diseasesAcute Coronary SyndromeHealthcare DisparitiesAgedRetrospective Studiesbusiness.industryPercutaneous coronary interventionCardiovascular AgentsHealth Status Disparitiesmedicine.diseaseST-segment elevation myocardial infarctionConcomitantPropensity score matchingConventional PCI1-year mortalityST Elevation Myocardial InfarctionPolandbusinesssex-differencesin-hospital mortality
researchProduct

MRI (Magnetic Resonance Imaging) in Psychiatry

2001

In recent years, structural and functional magnetic resonance imaging has opened up new avenues to the study of psychiatric disorders. A number of structural changes characteristic for different psychiatric diseases could be delineated by the use of magnetic resonance imaging (MRI). Functional magnetic resonance imaging (fMRI) enables the in vivo investigation of cerebral neuronal activation under cognitive or behavioral activation paradigms. Magnetic resonance spectroscopy (MRS) allows for the study of defined neurochemical substances or pharmacological agents in the human brain. This article presents an overview of the basic principles of the different MRI techniques and representative re…

Mri techniquesmedicine.medical_specialtymedicine.diagnostic_testMagnetic resonance imagingHuman brainNeuronal activationMRI - Magnetic resonance imagingmedicine.anatomical_structureNeurochemicalmedicineTreatment strategyPsychologyPsychiatryFunctional magnetic resonance imagingNeuroscience
researchProduct

Neurodegeneration in multiple sclerosis: novel treatment strategies.

2012

In recent years it has become clear that the neuronal compartment already plays an important role early in the pathology of multiple sclerosis (MS). Neuronal injury in the course of chronic neuroinflammation is a key factor in determining long-term disability in patients. Viewing MS as both inflammatory and neurodegenerative has major implications for therapy, with CNS protection and repair needed in addition to controlling inflammation. Here, the authors' review recently elucidated molecular insights into inflammatory neuronal/axonal pathology in MS and discuss the resulting options regarding neuroprotective and regenerative treatment strategies.

Multiple SclerosisInflammationNeuroprotectionmedicineAnimalsHumansPharmacology (medical)In patientMolecular Targeted TherapyNeuroinflammationNeuronsEvidence-Based Medicinebusiness.industryGeneral NeuroscienceMultiple sclerosisNeurodegenerationAnti-Inflammatory Agents Non-SteroidalNeurodegenerative Diseasesmedicine.diseasePathology of multiple sclerosisNeuroprotective AgentsTreatment strategyEducation Medical ContinuingNeurology (clinical)medicine.symptombusinessNeuroscienceExpert review of neurotherapeutics
researchProduct

Extrathoracic Lengthening (Kimura Technique)

2021

Treatment of congenital long gap esophageal atresia is extremely challenging. Cases are rare, variable, and oftentimes complex. Possible treatment options include delayed primary repair after initial gastrostomy, gastric transposition, intestinal interpositions, traction procedures, myotomy, and gastric tube techniques. Treatment strategies often consist of variations and combinations of different approaches.

Myotomymedicine.medical_specialtyLong gapbusiness.industrymedicine.medical_treatmentTreatment optionsLong gap esophageal atresiaGastrostomySurgeryPrimary repairMedicineTreatment strategyGastric transpositionbusiness
researchProduct

Special Situations in APL

2017

The introduction of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) as the mainstay therapy of acute promyelocytic leukemia (APL) has drastically changed the outcome of this hematologic malignancy into one of the first to receive a targeted treatment. Using frontline treatment strategies including these agents in combination with standard cytotoxic drugs has provided outstanding therapeutic results in most patients. In spite of the achievement of brilliant results in the majority of patients, some special situations still require the implementation of changes from the conventional therapeutic approach. In this chapter, we will review and discuss the management of APL in older and …

OncologyAcute promyelocytic leukemiamedicine.medical_specialtybusiness.industryGenetic variantsmedicine.diseaseLeukemiachemistry.chemical_compoundTherapeutic approachchemistryOlder patientsInternal medicinemedicineHematologic malignancyTreatment strategyArsenic trioxidebusiness
researchProduct

A prospective trial for defining a subset of patients with limited metastatic gastric cancer who may be candidates for bimodal treatment strategies: …

2012

4090 Background: The utility of surgery for metastatic gastric cancer is debated. A prospective trial was performed to evaluate a prognostic model for selecting patients (pts) treated with systemic chemotherapy (ct) who may also be candidates for surgical intervention. Methods: Using a predefined algorithm pts with untreated gastric cancer were prospectively stratified into 3 groups: operable (OD), limited metastatic (LD), or extensive metastatic (ED) disease and treated with 5-FU, oxaliplatin, leucovorin and docetaxel (FLOT). LD was defined as: distant intra-abdominal lymph node metastases only or/and a maximum of 1 organ involved, normal serum alkaline phosphatase, < 5 liver lesions, …

OncologyCancer Researchmedicine.medical_specialtyOncologyProspective trialbusiness.industryInternal medicinePrognostic modelMedicineTreatment strategybusinessMetastatic gastric cancerJournal of Clinical Oncology
researchProduct